Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609830 · ClinicalTrials.gov registry record · NA
GIOP Prevention Among People With Rheumatoid Arthritis
A NA study of Rheumatoid Arthritis and Osteoporosis, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 273
- Enrollment target
- 1
- Study location
NCT00609830: Completed NA study of Rheumatoid Arthritis and Osteoporosis, sponsored by University of North Carolina, Chapel Hill.
NCT00609830 is a NA study of Rheumatoid Arthritis and Osteoporosis that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 273 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00609830, a NA study of Rheumatoid Arthritis and Osteoporosis, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 273 participants
- Enrollment target
- 1
- Study location
Study Summary
The ultimate objective of the proposed research is to improve the health-related quality of life of individuals with rheumatoid arthritis by reducing their risk of developing osteoporosis secondary to glucocorticoid therapy. The study has four specific aims. Specific Aim 1: To obtain descriptive information concerning patients' knowledge, beliefs and behaviors with respect to osteoporosis and osteoporosis prevention. Specific Aim 2: To identify factors that discriminate among patients in different stages of change with respect to each behavior of interest. Specific Aim 3: To compare the effects of tailored versus generic educational materials on patient adherence to the ACR Guidelines for the Prevention of Glucocorticoid-Induced Osteoporosis. Specific Aim 4: To determine if the effects of tailored educational materials are enhanced by concurrent feedback of information concerning patients' behavioral risk factor status to their physicians.
Conditions Studied
Interventions
- BEHAVIORAL Tailored Materials
- BEHAVIORAL Tailored Materials Plus Physician Feedback
- BEHAVIORAL Generic Materials
- BEHAVIORAL No Information
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill School of Pharmacy - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2001-07 |
| Est. Completion | 2006-02 |
| Phase | NA |
What the finished NCT00609830 record still lists
NCT00609830 is an interventional study that assigns participants to a tested intervention. The registered 273 participants enrollment target is mid-sized for trials with a published cap, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 4 interventions - of which Tailored Materials is the first listed.
NCT00609830 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00609830 about?
NCT00609830 is a clinical study titled "GIOP Prevention Among People With Rheumatoid Arthritis". The ultimate objective of the proposed research is to improve the health-related quality of life of individuals with rheumatoid arthritis by reducing their risk of developing osteoporosis secondary to glucocorticoid therapy. The study has four specific aims. Specific Aim 1: To obtain descriptive in...
What is the current status of trial NCT00609830?
This trial is currently completed. It is a NA study. The enrollment target is 273 participants. The study started on 2001-07. Estimated completion is 2006-02.
What conditions does trial NCT00609830 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoporosis.
What interventions are being tested in trial NCT00609830?
The interventions under investigation include: Tailored Materials (BEHAVIORAL), Tailored Materials Plus Physician Feedback (BEHAVIORAL), Generic Materials (BEHAVIORAL), No Information (BEHAVIORAL).
Who is sponsoring clinical trial NCT00609830?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00609830 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00609830's enrollment target sits among peer trials
273 65th of 197 higher than 133 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
RECRUITING · NA
-
Improving Hypertension Control in Rheumatoid Arthritis
RECRUITING · NA
-
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07229430 · 273 participants · NA
Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia